Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Investor Alert: Robbins LLP Informs Investors of the Alarum Technologies Ltd. Class Action Lawsuit

Shareholder Notice: Robbins LLP Informs Investors of the ARS Pharmaceuticals Inc. Class Action

River City Bank Announces Pricing of Initial Public Offering

Stockholder Alert: Robbins LLP Informs Investors of the Gildan Activewear Inc. Class Action

BeOne Medicines anuncia resultados financeiros do segundo trimestre de 2026 e atualizações sobre os negócios

Nidec Announces a Request by a Shareholder to File an Action

Samenvatting: BeOne Medicines maakt de financiële resultaten over het tweede kwartaal van 2026 bekend en geeft een update over de bedrijfsactiviteiten

VSEE attributes changed: Attr: Fin_status D -> N;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

LEDS attributes changed: Attr: Fin_status D -> N;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

CNTX attributes changed: Attr: Fin_status N -> D;